ADSCs play a dual role in SSc by actively suppressing inflammation through the secretion of factors like the vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and interleukin-10 (IL-10), which collectively contribute to reducing fibrosis and encouraging angiogenesis. Here, IL10 is linked to systemic sclerosis.